A collaborative study was undertaken to evaluate the performance of currently marketed Mueller-Hinton agars from seven manufacturers by replicate disk diffusion tests with standard quality control strains. Identification of the manufacturers was concealed, and the resulting data were evaluated for the selection of a physical reagent standard against which the performance of future production lots would be tested and made to conform. A medium was selected which was sufficiently close to existing National Committee for Clinical Laboratory Standards quality control limits that current interpretive criteria would require minimum modification. Two of the seven lots were eliminated from further consideration because the final pHs were outside acceptable limits. The remaining four lots had 96% of mean zone diameters '2 mm from those of the chosen lot and 65% of the means were <1 mm from those of the chosen lot for all 28 antimicrobial agent-organism combinations. Manufacturers then attempted to produce new lots of Mueller-Hinton agar which performed within the prescribed limits of the chosen lot. One lot performed in close conformity with the selected standard, but the overall performance of the media was essentially the same as that of the randomly chosen lots in the initial study. It was concluded that one of the original seven lots demonstrated properties which made it a tentative candidate for a physical reagent standard and that the use of a physical reagent standard in evaluating production lots might aid in stabilizing the performance of Mueller-Hinton agar.
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The Bauer-Kirby disk diffusion susceptibility test was developed to provide a simple routine procedure which would reliably predict the efficacy of a given antibiotic regimen in the treatment of a specific infectious disease (3) .
Many technical factors affect the size and clarity of zones around the disks, including inoculum density, temperature, depth of agar, disk potency, reading of zones, and medium (1, 2, 4, 5, (7) (8) (9) (10) (11) (12) (13) (14) (16) (17) (18) (19) (20) . Ericsson and Sherris reported results from a large collaborative study in Europe, which included a number of institutions in different countries (8) . Variations in results were found with all antibiotics, especially tetracycline. Although the methods and media used in these laboratories were not always the same, the study pointed to a need for improved standardization of the methods used in disk diffusion susceptibility testing.
During the past decade a great deal of professional time has been expended to develop a standard method which would take into account the technical factors that contribute to variable results (15) . These efforts included development of quality control limits for standardized control strains and delineation of interpretive standards. As these standards have been used, it has become apparent that the original quality control limits did not adequately describe the performance of media in the field (12) .
Variations in Mueller-Hinton agar became most apparent with tetracyclines and aminoglycoside antibiotics (5, 9, 11, 16) . Cation content contributed to many of these variations (14) , and some workers have suggested that the magnesium and calcium content of Mueller-Hinton agar be adjusted to a predetermined level at the time that powder lots are manu-factured (17) . Subsequent studies revealed that this was not a practical approach since the cation contribution by the agar is unpredictable (11) . In The study was designed to determine the extent of variation in the performance of Mueller-Hinton agar lots currently available in the marketplace and the relationship of that performance to published control limits. Since the number of variables inherent in performing the test was high, this study was undertaken to determine whether it was possible to select an ideal lot from those in production to serve as a physical reagent standard against which the performance of future lots of Mueller-Hinton agar could be compared. Subsequently, a trial was undertaken to determine whether newly manufactured lots could be adjusted to perform similarly to the chosen standard.
Performance criteria for selecting a physical reagent standard were set up along with a test protocol for defining a reference medium. The results of these studies are reported here. Distribution of media. Bottles for transporting media lots were donated by Difco Laboratories and shipped to the CDC Biologic Products Division. Through the courtesy of Morris Suggs and R. Knox Harrell, this division served as the collection and distribution point for all media lots. Each manufacturer submitted 20 kg of a representative lot for testing. At CDC these lots were repackaged in the uniform bottles donated by Difco Laboratories and given a code number. Each participating laboratory had a different set of code numbers to ensure that investigators could not compare results. In addition, the name of the manufacturer of each coded lot was not revealed to any of the investigators or committee members. The coded powder lots were shipped to each of the five participating laboratories from CDC.
MATERIALS AND METHODS
Disks. Disks were provided through the courtesy of BBL Microbiology Systems. All disks were assayed at greater than 100% stated potency, except for cefoperazone and oxacillin, which had 93 and 97% of the stated potency, respectively. Antibiotics were selected to represent the spectrum of agents known to be affected by medium variations (Table 1) .
Laboratories. To eliminate as much variation as possible, independent laboratories at different institutions with experience in doing studies of this type and with a history of performing the disk test in a reproducible manner were selected. To firm up the performance of the standardized disk susceptibility test, technologists from each of the participating laboratories went to the CDC Antibiotic Investigational Laboratory for a final briefing on the details of the protocol and the need to follow the protocol precisely and to correct any misconceptions about the study design. Trial production of lots matching performance of proposed reagent reference standard. Each of the seven manufacturers received samples of the proposed reagent reference standard which was selected by the above criteria. Each manufacturer then attempted to adjust the performance of a newly manufactured lot of agar to match that of the standard. Evaluation of the newly manufactured lots was accomplished by testing each new lot in parallel with the reference reagent with the same adjusted inoculum and lot of disks. The differences between the means of 30 replicates tested on the same day for each of the 28 microorganism-drug combinations were statistically analyzed by a paired t test. The tentative criteria for accepting a lot of agar as essentially identical to the reference material were that the means of the lot for all 28 microorganism-drug combinations be within 1 mm of those observed with the proposed reference medium observed at the same time. Each manufacturer submitted the lot which they felt most closely fit these criteria to CDC for evaluation by the same protocol. Thirty replicates were selected, since it was determined, by using variance estimates from the first study, that this would be the number required for a high probability of detecting a 1-mm difference in means between two agar lots run in parallel (at = , = 0.01).
RESULTS
pH measurements. The five independent laboratories measured the pH of each batch of agar poured. The measurements were remarkably similar and revealed that lots 1 and 7 should be eliminated from consideration because they did not come within the required pH range of 7.2 to 7.4 ( Ranking of lots. The seven lots were ranked by the sum of the absolute differences between the midpoint for each of the 28 drug and organism combinations and the respective NCCLS midpoint. These ranks are presented in Table 3 , with a rank of 1 indicating the smallest midpoint deviation. Lot 5 gave the closest fit, while lots 3 and 7 were least close to existing midpoints (lots 7 and 1 had pHs outside the acceptable range).
The sums of the calculated control interval widths for the 28 microorganism-drug combinations were ranked for the seven lots, with the lot having the smallest sum given a rank of 1 (Table 3 ). Lot 7 exhibited the smallest amount of variation, while lot 1 showed the greatest.
The sum of the control interval widths was derived from control limits calculated with a formula for a variance estimate involving intralaboratory variability with 95% confidence limits. The sum of the widths of the control limits for all 28 microorganism-drug combinations derived by this method are given (Table 3) .
Comparison of performance of other lots to the one best meeting the criteria for selection. All lots were evaluated for similarities and differences and for determination of the lot which best met the current NCCLS midpoint standard and had the least variability (Table 3) . Lot 5 appeared to fit these criteria better than any of the other six lots and was tentatively selected as the new NCCLS reagent standard.
The means for the other six lots were compared to the mean for lot 5 to determine the extent of their variation from this lot (Table 4) . Of the 28 means, 13 were significantly different from those of lot 5 for lots 1 and 2, 7 from those of lot 3, and 9 from those of lot 4, and 11 of the 28 means for lots 6 and 7 were significantly different from the means for lot 5. Although some of the means were statistically different from those of lot 5, 92% of all means were within 2 mm and 65% were within 1 mm of the means for lot 5. A comparison of the four lots with the correct pH revealed that 65% of the means were within <1 mm of the mean of lot 5 and 96% were within c2 mm of this lot.
Streptococcus faecalis and Staphylococcus aureus testing. There was wide variation in the performance of the seven lots of agar with trimethoprim-sulfamethoxazole and Streptococcus faecalis (ATCC 29212 and ATCC 33186). Lots 3 and 4 gave no zone, while lots 2, 5, and 7 gave zones .20 mm and lots 1 and 6 gave smaller zones (<20 mm). Other species produced large clear zones of inhibition when trimethoprim-sulfamethoxazole disks were tested on lot 5.
Two strains of methicillin-resistant Staphylococcus aureus were selected by one of us (C.T.) for The number of antimicrobial agent-organism combinations which had greater than 1 mm difference between the mean zone diameters had not clearly decreased with media submitted by four of the five manufacturers (Table 5) . One manufacturer, however, improved its product sufficiently to allow it to be considered a possible second reference standard.
DISCUSSION
Variation in the performance of lots of Mueller-Hinton agar led us to develop a tightly controlled protocol which compared the performance of agar media currently on the market. The study was designed to determine whether a Reliable detection of methicillin resistance in Staphylococcus aureus presents a number of technical difficulties. On currently marketed Mueller-Hinton agar, some of these strains appear to be susceptible with methicillin disks but resistant (double zones) with oxacillin disks. The character of the growth within the zones of inhibition appears to be medium dependent with the strains that were tested. This problem requires careful consideration in setting any stan- The major question in developing a physical reagent standard for Mueller-Hinton agar was whether additional lots could be produced which performed essentially the same as the selected reference lot. In the initial study, overall performance for the media which had the proper pH was relatively uniform for production lots, but there were no data to demonstrate how closely it was possible to duplicate the performance of a new lot of agar medium with a reference reagent available for comparison. Additional studies were performed to answer that question.
When additional lots of agar were produced and tested in parallel with the selected physical standard, one manufacturer submitted a medium which was essentially the same in performance as the reference lot, that is, within 1 mm of the mean zone size for all microorganism-drug combinations. Four manufacturers submitted lots with performances which were not much closer to the selected standard than those of random lots that met the written standard.
Changing performance associated with variations in raw materials over a period of time may be eliminated by maintaining a standard reference medium with which manufacturers may compare the performance of future lots. While it appears that different manufacturers may not be able to produce lots of Mueller-Hinton agar with greater similarity in performance than is currently accomplished, the problem of drift in behavior of these media may be circumvented by comparing the performance of new lots with that of a physical reagent as well as against written criteria. A statistically valid performance test based on this principle is being developed.
